v1
P502 Tumour necrosis factor antagonists are superior to anti-integrin and anti-IL-12/23 therapies for preventing postoperative recurrence in adult Crohn’s disease patients requiring postoperative therapy
NobleIDNI6P92W48R52S26
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/7CD52FDF)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims